Ticker
SPRYCompany Name
ARS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cost of Revenue | Cost of Revenue Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 7.05M | 6.28% | $ 112.34M |
3/31/2025 | $ 2.07M | 2.13% | $ 97.12M |
12/31/2024 | $ 977K | 1.1% | $ 89.15M |
9/30/2024 | $ 112K | 4.36% | $ 2.57M |
6/30/2024 | $ 0 | 0% | $ 500K |
3/31/2024 | $ 0 | 0% | $ 10K |
12/31/2023 | $ 0 | 0% | $ 30K |
9/30/2023 | $ 0 | 0% | $ 1.35M |
6/30/2023 | $ 0 | 0% | $ 1.35M |
3/31/2023 | $ 0 | 0% | $ 1.34M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
COGS / Revenues
(=) COGS %
COGS % for ARS PHARMACEUTICALS INC is calculated as follows: COGS [ $ 0 ] / Revenues [ $ 0 ]
(=) COGS % [ 0% ]
Minimum
Dec 31, 2022
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.81K |
---|---|
min | -50.26% |
max | 172.25% |
average | 46.91% |
median | 50.54% |
std | 31.59% |